Metabolic dysfunction in anorexia nervosa

Obesity Research and Clinical Practice

Volumn 1, Issue 2, 2007, Pages 139-146

  Heilbronn, Leonie K ^a   Milner, Kerry Lee ^a   Kriketos, Adamandia ^c   Russell, Janice ^b   Campbell, Lesley V ^a  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anorexia nervosa; Body composition; Glucose metabolism; Lipid metabolism

Indexed keywords

ADIPONECTIN; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; GLUCOSE; INSULIN; LEPTIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANOREXIA NERVOSA; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLING; DIET RESTRICTION; DIETARY INTAKE; DISEASE ASSOCIATION; EXERCISE; FEMALE; GLUCOSE INTAKE; GLUCOSE METABOLISM; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; LOW DRUG DOSE; METABOLIC DISORDER; PRIORITY JOURNAL; THERMOGENESIS; TREATMENT DURATION; WEIGHT GAIN;

EID: 34247353750     PISSN: 1871403X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.orcp.2007.03.003     Document Type: Article

References (25)

1. Brichard S.M., Delporte M.L., and Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res 35 (2003) 337-342
2. Casper R.C., Schoeller D.A., Kushner R., Hnilicka J., and Gold S.T. Total daily energy expenditure and activity level in anorexia nervosa. Am J Clin Nutr 53 (1991) 1143-1150
3. Pirke K.M., Trimborn P., Platte P., and Fichter M. Average total energy expenditure in anorexia nervosa, bulimia nervosa, and healthy young women. Biol Psychiatry 30 (1991) 711-718
4. Russell J., Baur L.A., Beumont P.J., et al. Altered energy metabolism in anorexia nervosa. Psychoneuroendocrinology 26 (2001) 51-63
5. Zipfel S., Russell J., Baur L., Herzog W., and Beumont P.J. Impact of exercise on energy expenditure in anorexia nervosa. Psychosom Med 64 (2002) 133
6. Friedman J.M. Modern science versus the stigma of obesity. Nat Med 10 (2004) 563-569
7. Halaas J.L., Gajiwala K.S., Maffei M., et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269 (1995) 543-546
8. Montague C.T., Farooqi I.S., Whitehead J.P., et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387 (1997) 903-908
9. Bosy-Westphal A., Brabant G., Haas V., et al. Determinants of plasma adiponectin levels in patients with anorexia nervosa examined before and after weight gain. Eur J Nutr 44 (2005) 355-359
10. Hebebrand J., Exner C., Hebebrand K., et al. Hyperactivity in patients with anorexia nervosa and in semistarved rats: evidence for a pivotal role of hypoleptinemia. Physiol Behav 79 (2003) 25-37
11. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 (1996) 10697-10703
12. Yamauchi T., Kamon J., Minokoshi Y., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295
13. Castillo M., Scheen A., Lefebvre P.J., and Luyckx A.S. Insulin-stimulated glucose disposal is not increased in anorexia nervosa. J Clin Endocrinol Metab 60 (1985) 311-314
14. Fukushima M., Nakai Y., Taniguchi A., Imura H., Nagata I., and Tokuyama K. Insulin sensitivity, insulin secretion, and glucose effectiveness in anorexia nervosa: a minimal model analysis. Metabolism 42 (1993) 1164-1168
15. Pannacciulli N., Vettor R., Milan G., et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab 88 (2003) 1748-1752
16. Greenfield J.R., Samaras K., Chisholm D.J., and Campbell L.V. Regional Intra-Subject Variability in Abdominal Adiposity Limits Usefulness of Computed Tomography. Obes Res 10 (2002) 260-265
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
18. Matsuda M., and DeFronzo R. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470 [10.2337/diacare.22.9.1462]
19. Stumvoll M., Mitrakou A., Pimenta W., et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23 (2000) 295-301 [10.2337/diacare.23.3.295]
20. Russell J., Allen B., Mira M., Vizzard J., Stewart P., and Beumont P. Total body nitrogen as a predictor of clinical status in anorexia nervosa. Int J Eating Disord 15 (1994) 275-278
21. Iketani T., Nagata T., and Yamagami S. Altered body fat distribution after recovery of weight in patients with anorexia nervosa. Int J Eating Disord 26 (1999) 275-282
22. Nudel D.B., Gootman N., Nussbaum M.P., and Shenker I.R. Altered exercise performance and abnormal sympathetic responses to exercise in patients with anorexia nervosa. J Pediatr 105 (1984) 34-37
23. Pay H.E., Hardman A.E., Jones G.J., and Hudson A. The acute effects of low-intensity exercise on plasma lipids in endurance-trained and untrained young adults. Eur J Appl Physiol Occup Physiol 64 (1992) 182-186
24. Phillips S.M., Green H.J., Grant S.M., et al. Effect of acute plasma volume expansion on substrate turnover during prolonged low-intensity exercise. Am J Physiol Endocrinol Metab 273 (1997) E297-E304
25. Sparks L.M., Xie H., Koza R.A., et al. A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. Diabetes 54 (2005) 1926-1933